首页> Journal of cutaneous pathology> Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.

Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.

导出原文传递

翻译打印收藏纠错

第一作者： Mario L,Marques-Piubelli

第一单位： Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

作者： Mario L,Marques-Piubelli ^[1] ; Michael T,Tetzlaff ^[2] ; Priyadharsini,Nagarajan ^[3] ; Taylor C,Duke ^[4] ; Isabella C,Glitza Oliva ^[5] ; Debora A,Ledesma ^[1] ; Phyu P,Aung ^[3] ; Carlos A,Torres-Cabala ^[6] ; Ignacio I,Wistuba ^[2] ; Victor G,Prieto ^[6] ; Kelly C,Nelson ^[7] ; Jonathan L,Curry ^[8]

作者单位： Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[1] Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.;Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[2] Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[3] Department of Dermatology, The University of Texas Health Science Center, Houston, Texas, USA. ^[4] Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[5] Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.;Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[6] Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[7] Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.;Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.;Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[8]

关键词 XPO1 inhibitor anti-PD-1/PD-L1 therapy hypertrophic lichenoid dermatitis immune-related adverse event squamous cell carcinoma